EGFR and non-small cell lung carcinoma: Therefore, determining the original EGFR mutation status and monitoring the changes in mutations is crucial to the management of NSCLC,3, 8, 11, 12, 13 but biopsies are invasive procedures and can be technically impossible in some patients.